Wednesday , December 1 2021

Modern Strives for Covid-19 Fax Booster in Older Adults, High-Risk Individuals, News and Top Stories from the United States



[ad_1]

MASSACHUSETTS – (REUTERS) – Moderna said on Tuesday (October 12) that the US Food and Drug Administration (FDA) should authorize booster doses of its Covid -19 vaccine in fully vaccinated elderly adults and high-risk individuals.

The company said its data support the public health benefit of a booster dose of its vaccine to restore the immune response, while reducing the number of “breakthrough” infections in fully vaccinated adults.

Moderna’s comments were released in briefing documents ahead of a meeting Thursday and Friday of FDA’s foreign expert advisers to discuss booster dose of Moderna and Johnson & Johnson’s Covid-19 vaccines.

Rival Johnson & Johnson on Tuesday also cited data showing increased protection after a booster dose, which it said could be administered as early as two months after the original dose of their vaccine.



[ad_2]
Source link